Roth Capital analyst Scott Henry reiterated a Buy rating on Biodelivery Sciences (NASDAQ:BDSI) with a price target of $18.00, as the company announced that it …
In a research report sent to investors, William Blair analyst Tim Lugo reiterated an Outperform rating on Biodelivery Sciences (NASDAQ:BDSI) with a price …
